Nobody switches sales intelligence platforms for fun. The life-science BD teams we talk to who are evaluating a move off Zymewire respect what it does: the human-verified sponsor data is real, and for years it was the only serious option for CROs, CDMOs, and lab-services teams selling into biotech and pharma. What pushes them to look is a pattern, not a grudge: signals that surface after competitors have already called, pre-built filter columns that keep resurfacing the same well-known sponsors, and a stack bill that quietly doubled because Zymewire stops at intelligence and company emails, so a second contact-and-outreach tool rides along with it. If that list sounds familiar, this guide covers the switching-from-Zymewire process end to end: what maps to what, how to run the migration without a coverage gap, and what you genuinely give up.
TL;DR: Migration is a two-week parallel run, not a leap. Export your sponsor list, paste it into the new platform, and count which tool surfaces each signal first while both run side by side. Map your saved Zymewire segments to custom filters, replace the Zoudini add-on with native Salesforce sync, and consolidate the separate contact tool most teams pay for alongside Zymewire. You give up spreadsheet-style pre-built columns and a long-tenured curation team; you gain real-time discovery, custom filtering, verified contacts with phone numbers, and outreach in the same platform.
Why do teams actually switch?
Across our 2026 buyer conversations with life-science BD teams, three reasons dominate, and they are worth checking against your own experience before you invest in a migration.
Signal timing. The most common complaint is not accuracy, it is lateness: the trial signal or funding event shows up after the buying window opened. Part of that lag is structural for any tool that leans on registries, since ClinicalTrials.gov records lag actual status changes by a median of 142 days (peer-reviewed study). One BD leader set the bar for what intelligence is worth paying for: finding "one opportunity nobody else found ahead of time." Late signals fail that bar regardless of how well curated they are.
Filter rigidity. Zymewire segments sponsors through pre-built columns. They are deep, but when your motion needs a cut the columns do not offer, the same familiar sponsors keep coming back while newer accounts slip through. Teams describe wanting to flip the logic: cast wide, then filter on their own terms.
Stack cost. Zymewire provides company emails but not phone numbers or outreach. In practice, teams we speak with pay roughly $150 per user per month for Zymewire and another $300 to $450 for the contact-and-outreach tool next to it. The migration business case usually starts right there: one platform replacing two line items.
If none of these three are biting you, and your business is 100% pharma with a workflow built around human-checked records, staying put is a defensible call. The Zymewire vs Salesmotion comparison covers that decision honestly.
Run the two-week parallel test
Load your sponsor list into Salesmotion for Life Sciences and count which platform surfaces each signal first. That answers the switching question empirically.
What maps to what?
The mental model translates cleanly. Here is the mapping teams ask about most:
| Your Zymewire workflow | The Salesmotion equivalent |
|---|---|
| Saved sponsor segments (pre-built columns) | Custom filters across therapeutic area, phase, modality, funding, plus AI fit-ranking |
| Daily email alerts on sponsor activity | Real-time signal alerts, scoped to your accounts and keywords |
| Human-verified sponsor records | Source-linked briefs: every insight links to the underlying document |
| Contact reveal (company emails) | Verified decision-maker contacts with email and phone |
| Zoudini add-on for Salesforce | Native Salesforce sync (HubSpot too) |
| Manual outreach in a separate tool | AI-drafted outreach anchored to the triggering signal, in-platform |
| Stealth-biotech discovery | Continuous AI discovery from trials, filings, funding, and the open web |
The one Zymewire artifact with no direct equivalent is the spreadsheet-style column matrix itself. If your team's weekly ritual is stacking pre-built columns into a ranked list, expect a workflow change: the same result comes from custom filters plus fit-ranking, but it looks different on screen. Budget a session to rebuild your three most-used segments and the muscle memory follows.
“We had a variety of tools, and that was the pain — the variety. We had to go to multiple places to get streamlined data.”
Lyndsay Thomson
Head of Sales Operations, Cytel
How do you migrate without a coverage gap?
The safe pattern is a two-week parallel run. Nothing gets cancelled until the new platform has beaten the old one on your own accounts.
- Export your sponsor list. Pull your tracked sponsors from Zymewire (or your CRM, which is usually cleaner). All you need is the company domains.
- Paste the list into Salesmotion. Import is a paste of URLs; typical accounts process in about 15 minutes, large enterprises up to 2 hours. The bulk import guide covers the details.
- Rebuild your top segments as filters and keywords. Recreate your three most-used Zymewire segments first, and set keywords for the themes you sell into. Short, concrete phrases beat long descriptions; the keyword strategy guide shows the pattern.
- Run both platforms for two weeks and keep score. For every meaningful event at a tracked sponsor (trial milestone, raise, leadership change) note which platform told you first, and whether one missed it entirely. This turns the switching decision from a demo impression into data. Our signal freshness benchmarks explain why first-to-alert is the number that matters.
- Swap the Salesforce connection. Replace the Zoudini add-on with the native Salesforce integration, and map the fields your reps actually use. Run both connections briefly only if your admin wants a fallback; most teams cut over in a day.
- Consolidate the contact tool. Once verified contacts with phone numbers are flowing from sponsor profiles, the separate contact subscription becomes redundant. This is typically where the migration pays for itself.
- Cancel at the renewal boundary. Time the parallel run against your Zymewire renewal date so the overlap costs weeks, not a contract year.
What do you give up, honestly?
Two things, and they matter to some teams.
The human curation layer. Zymewire's data team hand-verifies sponsor records, and teams that have leaned on that trust for years feel the difference in approach. Salesmotion answers with source attribution instead of human sign-off: every insight links to the filing, article, or registry entry it came from, so reps verify in one click rather than trusting a curator they never meet. Different trust model, same goal. Teams that need an analyst-annotated data licence for drug-development decisions should keep one (that is Citeline's job, not a selling platform's).
The pharma-only depth of the column matrix. If your entire business is pharma sponsors and your BD motion is built around stacking those specific pre-built columns, the first week of custom filtering feels like more freedom than you asked for. The trade pays off when your targeting shifts, because you are no longer limited to the cuts the vendor predicted, but the first week is a real adjustment.
What you gain is the list from the mapping table: real-time discovery, custom filtering, contacts with phone numbers, outreach anchored to signals, and native CRM sync, in one platform. Cytel, a 2,000+ person clinical research organization, consolidated five tools into one and cut research time by 50%, and their head of sales operations credits the consolidation itself as much as any single feature.
Bring your Zymewire export to the demo
We will load your actual sponsor list live and show you what the signals look like on accounts you know.
Key Takeaways
- Switch for the right reasons: signal timing, filter rigidity, and two-tool stack cost are the patterns that make migration pay; curation nostalgia alone does not.
- Run a two-week parallel test and keep score on which platform surfaces each signal first; that turns the decision into data.
- Map your top three Zymewire segments to custom filters on day one; the column-matrix habit is the only real workflow change.
- Swap Zoudini for native Salesforce sync and consolidate the separate contact tool; the consolidation usually funds the migration.
- Time the cutover to your renewal date so the overlap costs weeks, not a year.
Frequently Asked Questions
How long does switching from Zymewire take?
The working migration is about two weeks: a day to import accounts and rebuild segments, then a parallel run while you compare signal timing on real events. Salesforce cutover is typically a day. The gating factor is usually your Zymewire renewal date, not the technical work.
Will I lose my historical Zymewire data?
Your sponsor list and CRM records are yours and move with you. Zymewire's curated record history stays in Zymewire, which is one reason to run the platforms in parallel rather than cutting over blind: by the end of the overlap, the new platform has built its own briefs and signal history on every account.
Can I keep Zymewire and add Salesmotion instead of switching?
Yes, and some teams do during a transition year. The economics rarely favor it long-term: the consolidation savings (Zymewire plus a contact tool versus one platform) are usually the strongest line in the business case. If 80%+ of your revenue is pharma and the human-curated records are load-bearing for you, the Zymewire alternatives comparison lays out when keeping both makes sense.
Does Salesmotion cover stealth and newly formed biotechs?
Yes. Discovery runs continuously from trials, filings, funding events, and the open web, so newly formed and stealth-mode companies surface as their first public traces appear rather than when a curated database adds them. Ask for a live look at recently surfaced companies in your therapeutic areas during a demo.
What does Salesmotion cost compared to Zymewire?
Zymewire does not publish pricing; life-science teams we speak with report roughly $150 per user per month, usually alongside a $300 to $450 contact tool. Salesmotion publishes pricing: individuals start at $85/month and team plans include the whole team, scaling by accounts monitored rather than seats. See pricing for current plans.
